Insmed reports second quarter 2021 financial results and provides business update

Bridgewater, n.j., aug. 5, 2021 /prnewswire/ -- insmed incorporated (nasdaq:insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended june 30, 2021 and provided a business update.
INSM Ratings Summary
INSM Quant Ranking